KLOW 80mg

KLOW is a four-peptide research blend that builds directly on the GLOW formula by adding KPV — a tripeptide derived from alpha-MSH — for studies requiring an additional anti-inflammatory research layer.

Blend Composition (per vial):
— GHK-Cu (Copper Peptide): 50mg
— BPC-157 (Body Protection Compound): 10mg
— TB-500 (Thymosin Beta-4): 10mg
— KPV (Lys-Pro-Val): 10mg
— Total: 80mg

The 5:1:1:1 ratio places GHK-Cu as the dominant compound, consistent with its higher effective concentration requirements in collagen and tissue remodeling research. KPV is the key differentiator from GLOW — it operates through NF-kB inhibition, making KLOW the preferred research model for studies involving inflammatory pathway suppression alongside regenerative signaling. Researchers studying gut barrier function, systemic inflammation models, or conditions where immune response intersects with tissue repair will find the four-compound design more applicable than a three-peptide model.

Supplied lyophilized in a sterile sealed vial. Third-party tested for identity and purity prior to release. Not for human consumption. For research use only.